These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 29246754)

  • 1. Thioctic acid in oral submucous fibrosis (India's disease) - A better tomorrow.
    Bhandarkar GP; Shetty KV; Kulkarni A
    J Stomatol Oral Maxillofac Surg; 2018 Apr; 119(2):129-134. PubMed ID: 29246754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of Aloe Vera and Antioxidant along with Physiotherapy in the Management of Oral Submucous Fibrosis.
    Singh N; Hebbale M; Mhapuskar A; Ul Nisa S; Thopte S; Singh S
    J Contemp Dent Pract; 2016 Jan; 17(1):78-84. PubMed ID: 27084867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study to evaluate the efficacy of lycopene and curcumin in oral submucous fibrosis patients: A randomized clinical trial.
    Saran G; Umapathy D; Misra N; Channaiah SG; Singh P; Srivastava S; Shivakumar S
    Indian J Dent Res; 2018; 29(3):303-312. PubMed ID: 29900913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral submucous fibrosis: An update on pathophysiology of malignant transformation.
    Arakeri G; Patil SG; Aljabab AS; Lin KC; Merkx MAW; Gao S; Brennan PA
    J Oral Pathol Med; 2017 Jul; 46(6):413-417. PubMed ID: 28391621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An enigmatic pathogenetic mechanism of hypoxia inducible factor - 1/2 alpha in the progression of fibrosis of oral submucous fibrosis and its malignant transformation: A systematic review and meta-analysis.
    R K; Chandra A; Jain T; Singh N; Agrawal R
    Arch Oral Biol; 2024 Jun; 162():105944. PubMed ID: 38492547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential role of fibroblast senescence in malignant transformation of oral submucous fibrosis.
    Bijai LK; Muthukrishnan A
    Oral Oncol; 2022 Apr; 127():105810. PubMed ID: 35303624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral submucous fibrosis--a treatment protocol based on clinical study of 100 patients in central India.
    Lambade P; Dawane P; Thorat P
    Oral Maxillofac Surg; 2015 Jun; 19(2):201-7. PubMed ID: 25511574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of serum beta carotene levels in patients with oral submucous fibrosis in India.
    Aggarwal A; Shetti A; Keluskar V; Bagewadi A
    J Oral Sci; 2011 Dec; 53(4):427-31. PubMed ID: 22167026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An update on studies on etiological factors, disease progression, and malignant transformation in oral submucous fibrosis.
    Bari S; Metgud R; Vyas Z; Tak A
    J Cancer Res Ther; 2017; 13(3):399-405. PubMed ID: 28862199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant transformation of oral submucous fibrosis in Taiwan: A nationwide population-based retrospective cohort study.
    Yang PY; Chen YT; Wang YH; Su NY; Yu HC; Chang YC
    J Oral Pathol Med; 2017 Nov; 46(10):1040-1045. PubMed ID: 28295637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative evaluation of curcumin and antioxidants in the management of oral submucous fibrosis.
    Rai A; Kaur M; Gombra V; Hasan S; Kumar N
    J Investig Clin Dent; 2019 Nov; 10(4):e12464. PubMed ID: 31605442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High risk of malignant transformation of oral submucous fibrosis in Pakistani females: A potential national disaster.
    Mohiuddin S; Fatima N; Hosein S; Fatima N
    J Pak Med Assoc; 2016 Nov; 66(11):1362-1366. PubMed ID: 27812049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why do Only Certain Cases of Oral Submucous Fibrosis Undergo Malignant Transformation?
    Yuwanati M; Sarode SC; Gadbail A; Gondivkar S; Sarode GS; Patil S
    J Contemp Dent Pract; 2021 May; 22(5):463-464. PubMed ID: 34318761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breath Alkane as an index of severity for oral submucous fibrosis: A new perspective?
    Arakeri G; Boraks G; Aljabab AS; Patil SG; Merkx MA; Brennan PA
    Med Hypotheses; 2017 Jan; 98():18-20. PubMed ID: 28012596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral submucous fibrosis as a precancerous condition.
    Pindborg JJ; Murti PR; Bhonsle RB; Gupta PC; Daftary DK; Mehta FS
    Scand J Dent Res; 1984 Jun; 92(3):224-9. PubMed ID: 6589738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Stem Cells in the Pathogenesis and Malignant Transformation of Oral Submucous Fibrosis.
    Kizhakkoottu S; Ramani P; Tilakaratne WM
    Stem Cell Rev Rep; 2024 Aug; 20(6):1512-1520. PubMed ID: 38837114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Therapeutic Efficacy of Different Treatment Modalities in Oral Submucous Fibrosis: A Comparative Study.
    Tp B; T AG; Varghese M; Raghavan R; Vm MN; Pius A
    J Contemp Dent Pract; 2019 Mar; 20(3):390-394. PubMed ID: 31204333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Better grade of tumor differentiation of oral squamous cell carcinoma arising in background of oral submucous fibrosis.
    Sarode SC; Sarode GS
    Med Hypotheses; 2013 Oct; 81(4):540-3. PubMed ID: 23891040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of topical tulsi (
    Biswas D; Naik Z; Kumar SL; Patil N; Bagewadi A
    Indian J Dent Res; 2022; 33(2):146-151. PubMed ID: 36254950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lactate dehydrogenase as a biomarker in oral cancer and oral submucous fibrosis.
    Kallalli BN; Rawson K; Muzammil ; Singh A; Awati MA; Shivhare P
    J Oral Pathol Med; 2016 Oct; 45(9):687-690. PubMed ID: 27132033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.